470 reports of this reaction
2.5% of all TIMOLOL reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for TIMOLOL, manufactured by Thea Pharma Inc.. There are 470 FDA adverse event reports linking TIMOLOL to FATIGUE. This represents approximately 2.5% of all 19,009 adverse event reports for this drug.
Patients taking TIMOLOL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for TIMOLOL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for TIMOLOL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 470 FDA reports for TIMOLOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.5% of all adverse event reports for TIMOLOL, making it one of the most commonly reported side effect.
If you experience fatigue while taking TIMOLOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.